MedPath

THE study of unani drug Majoon e vaj in patients involving inability to recall important personal information that would not typically be lost with ordinary forgetting

Phase 2
Conditions
Health Condition 1: F440- Dissociative amnesia
Registration Number
CTRI/2023/06/053818
Lead Sponsor
IUM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Any gender between 18-46 years of age.

Subjects diagnosed as having Dissocative Amnesia along with Dissociative Fugue (DA with DF) on account of DSM 5 criteria, and taking any medication for this.

Subjects having sufficient competence to understand and answer the questions of the investigator.

Exclusion Criteria

Subjects with ordinary forgetfulness, episodes of trance disorder, possession disorder, partial dissocative identity disorder, any other disorder, or any combination of those disorders.

Subjects with tendency of suicidality

k/c/o substance abuse, Current life-crisis (i.e., ongoing abuse, divorce, a somatic disease in spouse or children etc.).

Subjects with Ongoing psychotic episodes.

Neurological diseases, mental disability or life-threatening somatic diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in Autobiographical Memory Intreview(AMI)Timepoint: 2 months
Secondary Outcome Measures
NameTimeMethod
Decrease in DDIS score <br/ ><br> <br/ ><br>Timepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath